Type Whole antibody Target HGF CAS Number 1174900-84-5 | Source Humanized (from mouse) ATC code none ChemSpider none | |
Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.
Ficlatuzumab was developed by AVEO Pharmaceuticals. In May 2012, AVEO released results of a Phase II clinical trial comparing gefitinib alone and in combination with ficlatuzamab in treatment-naive Asian patients with non-small cell lung cancer.
References
Ficlatuzumab Wikipedia(Text) CC BY-SA